<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04877548</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL20_1032</org_study_id>
    <nct_id>NCT04877548</nct_id>
  </id_info>
  <brief_title>Powdered Fermented Fruits for Glycemia Reduction</brief_title>
  <acronym>P2F-GR</acronym>
  <official_title>Randomized Pilot Study to Measure the Effects of an Acute Intake of Fermented Fruits Flours on Postprandial Glycaemic Response and Metabolic Profile</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the effects of an acute intake of two fermented fruits&#xD;
      flours as part of a standardized breakfast, in comparison with the acute intake of a&#xD;
      standardized breakfast without fermented fruits flour but with the same amount of available&#xD;
      carbohydrates, on postprandial glycaemic response and overall metabolism in subjects at&#xD;
      cardiometabolic risk.&#xD;
&#xD;
      The metabolic parameters will be assessed in fasting and in postprandial period after the&#xD;
      consumption of the standardized breakfast.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 7, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incremental area under curve (iAUC 0-240 min) of postprandial glycaemia in response to an acute intake of different standardized breakfast including or not a fermented fruits flour but which all contain similar amount of available carbohydrate.</measure>
    <time_frame>Through study completion, an average of 18 days</time_frame>
    <description>Glycaemia will be measured at time t-30, 0, 15, 30, 45, 60, 90, 120, 180, 240 (when taking the standardized breakfast).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximum value, total and incremental area under curve (iArea Under Curve and tArea Under Curve 0-120, 0-240 and 120-240 min) of glycaemia and insulinemia</measure>
    <time_frame>Through study completion, an average of 18 days</time_frame>
    <description>Glycaemia and insulinemia will be measured at time t-30, 0, 15, 30, 45, 60, 90, 120, 180, 240 (when taking the standardized breakfast).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycaemia tArea Under Curve/insulinemia tArea Under Curve ratio (0-120 and 0-240 min)</measure>
    <time_frame>Through study completion, an average of 18 days</time_frame>
    <description>Glycaemia and insulinemia will be measured at time t-30, 0, 15, 30, 45, 60, 90, 120, 180, 240 (when taking the standardized breakfast).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum value, total and incremental area under curve (iArea Under Curve and tArea Under Curve 0-120, 0-240 and 120-240 min) of digestive hormones (GLP-1 and ghrelin)</measure>
    <time_frame>Through study completion, an average of 18 days</time_frame>
    <description>GLP-1 and ghrelin concentrations will be measured at time t-30, 0, 15, 30, 45, 60, 90, 120, 180, 240 and t0, 60, 120, 180, 240 respectively (when taking the standardized breakfast).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum value, total and incremental area under curve (iArea Under Curve and tArea Under Curve 0-240 min) of expired gases (H2, CH4)</measure>
    <time_frame>Through study completion, 24 hours following the last day</time_frame>
    <description>Expired gases concentrations will be measured at time t-30, 0, 60, 120, 180, 240, 360, 480, before the diner and the breakfast next day (24 hours following the standardized breakfast intake).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidation of energy substrates (carbohydrates, lipids, proteins) and induced-food thermogenesis</measure>
    <time_frame>Through study completion, an average of 18 days</time_frame>
    <description>Indirect calorimetry measurement during the postprandial period (0-240 min) (when taking the standardized breakfast).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satiety and digestive tolerance</measure>
    <time_frame>Through study completion, 24 hours following the last day</time_frame>
    <description>Visual analogue scales (VAS) on gastrointestinal symptoms and questionnaires on the consistency and frequency of stools completed, when taking the standardized breakfast (24 hours following the standardized breakfast intake).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline characteristics</measure>
    <time_frame>Day 0 (at fasting before the standardized breakfast intake)</time_frame>
    <description>Anthropometric parameters&#xD;
height (cm),&#xD;
waist and hip circumference (cm),</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary intake</measure>
    <time_frame>Through study completion, an average of 18 days</time_frame>
    <description>Dietary records completed (the day before and the day of the standardized breakfast intake).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline characteristics</measure>
    <time_frame>Day 0 (at fasting before the standardized breakfast intake)</time_frame>
    <description>Anthropometric parameters:&#xD;
- weight (kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline characteristics</measure>
    <time_frame>Day 0 (at fasting before the standardized breakfast intake)</time_frame>
    <description>Anthropometric parameters:&#xD;
- body composition (lean body mass and fat mass by impedance)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline characteristics</measure>
    <time_frame>Day 0 (at fasting before the standardized breakfast intake)</time_frame>
    <description>Metabolic parameters (glycaemia, insulinemia).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline characteristics</measure>
    <time_frame>Day 0 (at fasting before the standardized breakfast intake)</time_frame>
    <description>Digestive hormones (GLP-1, ghrelin)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline characteristics</measure>
    <time_frame>Day 0 (at fasting before the standardized breakfast intake)</time_frame>
    <description>Expired gases (H2, CH4)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline characteristics</measure>
    <time_frame>Day 0 (at fasting before the standardized breakfast intake)</time_frame>
    <description>Resting metabolic rate.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Cardiometabolic Risk Factors</condition>
  <condition>Obesity, Abdominal</condition>
  <arm_group>
    <arm_group_label>Fermented orange flour</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Volunteers will have to consume a standardized breakfast including fermented orange flour and presenting 50g of available carbohydrates</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fermented grape flour</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Volunteers will have to consume a standardized breakfast including fermented grape flour and presenting 50g of available carbohydrates</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Volunteers will have to consume a standardized breakfast without fermented flour but also presenting 50g of available carbohydrates</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fermented orange flour</intervention_name>
    <description>Volunteers will have to consume a standardized breakfast including fermented orange flour and presenting 50g of available carbohydrates</description>
    <arm_group_label>Fermented orange flour</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fermented grape flour</intervention_name>
    <description>Volunteers will have to consume a standardized breakfast including fermented grape flour and presenting 50g of available carbohydrates</description>
    <arm_group_label>Fermented grape flour</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Volunteers will have to consume a standardized breakfast without fermented flour but also presenting 50g of available carbohydrates</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Body Mass Index between 25 and 35 kg/m2 inclusive&#xD;
&#xD;
          -  Waist circumference &gt; 80 cm for women and &gt; 96 cm for men&#xD;
&#xD;
          -  Fibers intake ≤ 25g/day&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of digestive surgery or diseases&#xD;
&#xD;
          -  Current or recent (&lt;12 weeks) intake of antibiotics or gastro-intestinal medicinal&#xD;
             product&#xD;
&#xD;
          -  Current probiotics, prebiotics, fibers complement, and/or any products modulating&#xD;
             glucose and lipid metabolism&#xD;
&#xD;
          -  Volunteer with a dietary restriction (vegetarian or high-protein diet for example)&#xD;
&#xD;
          -  Current weight loss diet&#xD;
&#xD;
          -  Pregnant or lactating woman or woman who do not use effective contraception&#xD;
&#xD;
          -  Drinking more than 3 glasses of alcohol per day (&gt;30g/day)&#xD;
&#xD;
          -  Smoking volunteer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathalie FEUGIER-FAVIER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Recherche en Nutrition Humaine Rhône-Alpes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nathalie FEUGIER-FAVIER, MD</last_name>
    <phone>4 78 86 19 72</phone>
    <phone_ext>+33</phone_ext>
    <email>nathalie.feugier@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julie-Anne NAZARE, PhD</last_name>
    <phone>4 78 86 23 22</phone>
    <phone_ext>+33</phone_ext>
    <email>julie-anne.nazare@univ-lyon1.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre de Recherche en Nutrition Humaine Rhône-Alpes</name>
      <address>
        <city>Pierre-Bénite</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie FEUGIER-FAVIER, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 26, 2021</study_first_submitted>
  <study_first_submitted_qc>May 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2021</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Postprandial glycaemia</keyword>
  <keyword>Dietary fibers</keyword>
  <keyword>Cardiometabolic risk</keyword>
  <keyword>Fermented fruit flour</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

